A generic image of a pen on top of a stock chart.
Markets

Novo A Buys AnaptysBio Inc, ObsEva SA, Dermira Inc, Sells Vanguard Total Stock Market, CoLucid ...

Novo A

  • New Purchases: ANAB , OBSV , AKBA ,
  • Added Positions:DERM, XLRN,
  • Sold Out:VTI, CLCD, VGK,

For the details of Novo A's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Novo+A

These are the top 5 holdings of Novo A

  1. Inogen Inc ( INGN ) - 3,549,320 shares, 29.54% of the total portfolio.
  2. AnaptysBio Inc ( ANAB ) - 3,033,504 shares, 9.03% of the total portfolio. New Position
  3. Reata Pharmaceuticals Inc ( RETA ) - 3,367,763 shares, 8.18% of the total portfolio.
  4. iRhythm Technologies Inc ( IRTC ) - 2,024,448 shares, 8.17% of the total portfolio.
  5. Corvus Pharmaceuticals Inc ( CRVS ) - 3,224,046 shares, 7.18% of the total portfolio.

New Purchase: AnaptysBio Inc ( ANAB )

Novo A initiated holdings in AnaptysBio Inc. The purchase prices were between $16.62 and $28.78, with an estimated average price of $23.3. The stock is now traded at around $24.81. The impact to the portfolio due to this purchase was 9.03%. The holdings were 3,033,504 shares as of 2017-03-31.

New Purchase: ObsEva SA (OBSV)

Novo A initiated holdings in ObsEva SA. The purchase prices were between $10.41 and $13.99, with an estimated average price of $12.28. The stock is now traded at around $6.31. The impact to the portfolio due to this purchase was 3.4%. The holdings were 3,044,093 shares as of 2017-03-31.

New Purchase: Akebia Therapeutics Inc (AKBA)

Novo A initiated holdings in Akebia Therapeutics Inc. The purchase prices were between $8.94 and $10.55, with an estimated average price of $9.76. The stock is now traded at around $15.69. The impact to the portfolio due to this purchase was 1.26%. The holdings were 1,272,247 shares as of 2017-03-31.

Added: Dermira Inc (DERM)

Novo A added to the holdings in Dermira Inc by 245.51%. The purchase prices were between $27.98 and $38.03, with an estimated average price of $32.26. The stock is now traded at around $29.93. The impact to the portfolio due to this purchase was 1.95%. The holdings were 748,240 shares as of 2017-03-31.

Added: Acceleron Pharma Inc (XLRN)

Novo A added to the holdings in Acceleron Pharma Inc by 25.30%. The purchase prices were between $23.3 and $30.17, with an estimated average price of $26.35. The stock is now traded at around $29.64. The impact to the portfolio due to this purchase was 0.89%. The holdings were 1,553,937 shares as of 2017-03-31.

Sold Out: Vanguard Total Stock Market (VTI)

Novo A sold out the holdings in Vanguard Total Stock Market. The sale prices were between $115.32 and $123.44, with an estimated average price of $119.72.

Sold Out: CoLucid Pharmaceuticals Inc (CLCD)

Novo A sold out the holdings in CoLucid Pharmaceuticals Inc. The sale prices were between $31.95 and $46.53, with an estimated average price of $43.26.

Sold Out: Vanguard FTSEEuropean (VGK)

Novo A sold out the holdings in Vanguard FTSEEuropean. The sale prices were between $47.94 and $51.64, with an estimated average price of $49.87.

Premium Members

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ANAB IRTC INGN CRVS RETA

Other Topics

Stocks

Latest Markets Videos